Brightstone Venture Capital

The global computational biology market size is expected to reach USD 13.6 billion by 2024 | PR Newswire | 10/28/2019

… from angel investors. For instance, in February 2019 , StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD …

David Dalvey - Twin Cities Business | 10/1/2019

Navarre Corporation (1995–1998) It’s been relatively rare for Minnesota companies to go public in recent years. Plymouth–based biotech firm Celcuity Inc. has been one of the few exceptions, completing its initial public offering in 2017. The IPO grossed $26.2 million, before fees, for the company, which does not yet have any revenue and effectively remains a startup. Brian Sullivan is the public face of Celcuity. He co-founded …

Follow Brightstone Venture Capital:    

Why Entrepreneurs Seeking Venture Capital Need Compelling Stories | 6/13/2019

11 Views “Who cares?” It’s the first question to ask when building a story for any entrepreneur who intends to approach institutional investors, says David Dalvey , founder of Brightstone Venture Capital in Minneapolis. With more than 25 years of experience reviewing and investing in early-stage business opportunities, Dalvey usually knows within minutes whether to continue talking with the founder of a new company. His first and most important screen …

NIH taps StemoniX’s organ-on-a-chip for opioid, addiction research | FierceBiotech | 5/1/2019

The NIH’s National Center for Advancing Translational Sciences is teaming up with StemoniX to use its brain-on-a-chip platform to test new treatments for pain, opioid misuse and addiction. Under an addiction-focused program dubbed NIH HEAL (Helping to End Addiction Long-term), the partners will screen a library of opioid and neuronal signaling compounds using the platform, known as microBrain 3D. MicroBrain is a functioning, spherical human …

Global Computational Biology Market 2019-2026: Analysis on Cellular & Biological Simulation, Drug Discovery and Disease Modelling - ResearchAndMarkets.com | Business Wire | 4/10/2019

… from angel investors. For instance, in February 2019, StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD …

StemoniX

The global computational biology market size is expected to reach USD 13.6 billion by 2024 | PR Newswire | 10/28/2019

StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD 5.0 million to speed up the discovery of …

The global computational biology market size is expected to reach USD 13.6 billion by 2024 | Svy | wfmz.com | 10/28/2019

StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD 5.0 million to speed up the discovery of …

Mayo Clinic

The global computational biology market size is expected to reach USD 13.6 billion by 2024 | PR Newswire | 10/28/2019

Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD 5.0 million to speed up the discovery of new drugs. With this finding, the research institute is planning to procure and install drug discovery research instruments and other drug discovery platforms. Further key findings …

The global computational biology market size is expected to reach USD 13.6 billion by 2024 | Svy | wfmz.com | 10/28/2019

Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD 5.0 million to speed up the discovery of new drugs. With this finding, the research institute is planning to procure and install drug discovery research instruments and other drug discovery platforms. Further key findings …